Shuren To Lawmakers: Sequestration Is “Killing Us”
This article was originally published in The Gray Sheet
Executive Summary
CDRH Director Jeffrey Shuren fears the center won’t be able to meet commitments to hire new employees for FY 2014 if the sequester continues, he told members of the House Energy & Commerce Health Subcommittee last week.
You may also be interested in...
News Briefs: Senate Introduces User Fee Bill; Lawsuit Ends Over Conflict Minerals
Senators try to shield FDA user fees from sequestration. Court rejects business groups’ challenge to conflict minerals reporting law. More news in brief
CDRH Sequestration Impact: Training, Standards And Reg Science
CDRH Director Jeffrey Shuren detailed last week how federal sequestration cuts to FDA are impacting specific device center programs, including training, standards development and regulatory science. Shuren also signaled imminent policy releases from the center, including a finalized post-market surveillance plan.
FDA Issues Work Plan For Independent Assessment Of Pre-market Review Process
The assessment, called for by industry during the device user fee reauthorization, will be conducted by an independent consulting firm. The goal is to identify efficiencies in the device review process.